Business

CHICAGO, July 31 (Reuters) – Quest Diagnostics (DGX.N) on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer’s disease protein that can appear years before dementia symptoms arise.The $399 test, called AD-Detect, uses the same technology as a blood test the company began selling for use by… […]

LONDON, July 31 (Reuters) – Global education group Pearson said it was on course to hit annual and mid-term targets after demand for English language learning, exams and qualifications helped it to beat market expectations with 44% growth in profit in its first half.The British group on Monday posted adjusted operating profit of 250 million… […]

NEW YORK, July 31 (Reuters) – Groundbreaking treatments for Alzheimer’s disease that work by removing a toxic protein called beta amyloid from the brain may benefit whites more than Black Americans, whose disease may be driven by other factors, leading Alzheimer’s experts told Reuters.The two drugs – Leqembi, from partner biotech firms Eisai (4523.T) and… […]

Revenues up 6.7% in H1 to 1.42 bln eurosOperating income up 7.2% in H1 to 456 mln eurosShipped 5,341 cars globally in H1, 1,625 in the U.S.EMEA largest region with 2,285 cars shipped in H1MILAN, July 31 (Reuters) – Lamborghini could sell 10,000 cars this year for the first time, its CEO said, as the… […]

July 31 (Reuters) – Manchester United (MANU.N) signed a 900 million pound ($1.1 billion) deal with Adidas (ADSGn.DE) on Monday, renewing the English soccer club’s partnership with its official kit supplier for 10 more years.Manchester United, whose U.S. owners have been considering selling the Premier League club, will return to the lucrative UEFA Champions League… […]